Dawod Abdelhaq

Roswell Park Comprehensive Cancer Center

Papers

1

Total Citations

4

H-Index

1

About

Dawod Abdelhaq is a urologic surgeon and clinical researcher whose work focuses on improving surgical outcomes in patients undergoing robot-assisted radical cystectomy (RARC) for bladder cancer. His most cited study, a randomized controlled trial published in 2025, investigates whether prophylactic antibiotics reduce the rate of urinary tract infections within 90 days following RARC—a critical question given the high infection burden in this population. With 4 citations already, this work has quickly drawn attention for its rigorous methodology and direct clinical relevance. Abdelhaq’s research sits at the intersection of surgical oncology, infection prevention, and evidence-based perioperative care. By addressing a common and costly complication, his contributions help refine postoperative protocols and enhance patient recovery. His findings offer actionable insights for urologists and highlight the importance of randomized trials in shaping surgical standards. For students and researchers, Abdelhaq’s work exemplifies how targeted clinical studies can translate into meaningful improvements in patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Do Prophylactic Antibiotics Decrease the Rate of Urinary Tract Infections After Robot-Assisted Radical Cystectomy? A Randomized Controlled Trial
4 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Roswell Park Comprehensive Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago